Empirical therapy for symptomatic gastroesophageal reflux disease in primary care: Determinants of efficacy

Digestion

Volumn 76, Issue 3-4, 2007, Pages 207-214

  Arts, J ^a   Eisendrath, P ^b   Deviere J ^b   Tack, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Gastroesophageal reflux disease; Reflux esophagitis; Reflux questionnaire; Symptom assessment, GERD; Treatment response

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEPTIC ULCER; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SYMPTOMATOLOGY; TREATMENT FAILURE;

ADULT; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE; TREATMENT OUTCOME;

EID: 40449124055     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112648     Document Type: Article

References (21)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group: The Montreal definition and classification of gastroesophageal reflux disease: a global evidencebased consensus. Am J Gastroenterol 2006;101:1900-1920.
2. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
3. Isolauri J, Laippala P: Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
4. Louis E, DeLooze D, Deprez P, Hiele M, Urbain D, Pelckmans P, Devière J, Deltenre M: Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 2002;14:279-284.
5. Mason J, Hungin AP: Review article: gastrooesophageal reflux disease - the health economic implications. Aliment Pharmacol Ther 2005;22(Suppl 1):20-31.
6. Cohen S, Parkman HP: Heartburn - a serious symptom. N Engl J Med 1999;340:878-879.
7. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999;44(Suppl 2):S1-S16.
8. Dent J: Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50 (Suppl 4):iv17-iv20.
9. Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, Haug K, de Groot G, van Oudvorst A, Dalvag A, Junghard O, Wiklund I: Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998;10:119-124.
10. Johnsson F, Roth Y, Damgaard Pedersen NE, Joelsson B: Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther 1993;7:81-86.
11. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J: Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370-1376.
12. American Society for Gastrointestinal Endoscopy: The role of endoscopy in the management of GERD: guidelines for clinical application. Gastrointest Endosc 1999;49:834-835.
13. Poelmans J, Feenstra L, Demedts I, Rutgeerts P, Tack J: The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol 2004;99:1419-1426.
14. Galmiche JP, Barthelemy P, Hamelin B: Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765-773.
15. Texte du Groupe de Travail: Conférence de Consensus. Comment diagnostiquer un RGO? Gastroentérol Clin Biol 1999;23:S202-S207.
16. Eisendrath P, Tack J, Devière J: Diagnosis of gastroesophageal reflux disease in general practice: a Belgian national survey. Endoscopy 2002;34:998-1003.
17. Vallot T, Bruley des Varannes S, Grimaud JC, Ruszniewski P, Richard A, Gentin F, Slama A: Epidemiology of gastro-oesophageal reflux in general practice: predictive factors for health care utilization in the course of a year (in French). Gastroentérol Clin Biol 1999;23:1139-1144.
18. van Pinxteren B, Numans ME, Lau J, de Wit NJ, Hungin AP, Bonis PA: Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med 2003;18:755-763.
19. Armstrong D, Pare P, Pericak D, Pyzyk M; Canadian Pantoprazole GERD Study Group: Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am J Gastroenterol 2001;96:2849-2857.
20. Brun J, Sörngård H: High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care. Fam Pract 2000;17:401-404.
21. Fransen GA, Janssen MJ, Muris JW, Laheij RJ, Jansen JB: Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy. Aliment Pharmacol Ther 2004;20:1045-1052.